GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Biotech Ltd (NSE:MEDICAMEQ) » Definitions » 3-Year Revenue Growth Rate

Medicamen Biotech (NSE:MEDICAMEQ) 3-Year Revenue Growth Rate : 15.40% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medicamen Biotech 3-Year Revenue Growth Rate?

Medicamen Biotech's Revenue per Share for the three months ended in Dec. 2024 was ₹35.53.

During the past 12 months, Medicamen Biotech's average Revenue per Share Growth Rate was 5.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 15.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Medicamen Biotech was 16.80% per year. The lowest was -18.50% per year. And the median was 0.00% per year.


Competitive Comparison of Medicamen Biotech's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Biotech's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicamen Biotech's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicamen Biotech's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Medicamen Biotech's 3-Year Revenue Growth Rate falls into.


;
;

Medicamen Biotech 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Medicamen Biotech  (NSE:MEDICAMEQ) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Medicamen Biotech 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Medicamen Biotech's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicamen Biotech Business Description

Traded in Other Exchanges
Address
1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019
Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.

Medicamen Biotech Headlines

No Headlines